Provided by Tiger Trade Technology Pte. Ltd.

Medicus Pharma Ltd.

0.0921
-0.0098-9.62%
Post-market: 0.0845-0.0076-8.25%19:48 EDT
Volume:17.32M
Turnover:1.77M
Market Cap:5.82M
PE:-0.06
High:0.0948
Open:0.0865
Low:0.0840
Close:0.1019
52wk High:2.78
52wk Low:0.0840
Shares:63.18M
Float Shares:46.69M
Volume Ratio:3.74
T/O Rate:37.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6597
EPS(LYR):-2.7356
ROE:-7446.11%
ROA:-110.67%
PB:-3.30
PE(LYR):-0.03

Loading ...

Jun 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 29, 2025

Correspondence

Form CORRESP - Correspondence
May 29, 2025

Correspondence

Form CORRESP - Correspondence
May 28, 2025

Correspondence

Form CORRESP - Correspondence
May 27, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 27, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Correspondence

Form CORRESP - Correspondence
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Oct 15, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]